We are live on ! Find out more
MGNX icon

MacroGenics

137 hedge funds and large institutions have $1.42B invested in MacroGenics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 39 increasing their positions, 46 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more capital invested

Capital invested by funds: $266M → $1.42B (+$1.15B)

63% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 24

12.78% more ownership

Funds ownership: 91.86%104.64% (+13%)

12% more funds holding

Funds holding: 122137 (+15)

2% more call options, than puts

Call options by funds: $5.63M | Put options by funds: $5.52M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 46

Holders
137
Holders Change
+15
Holders Change %
+12.3%
% of All Funds
2.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
39
Increased
39
Reduced
46
Closed
24
Calls
$5.63M
Puts
$5.52M
Net Calls
+$117K
Net Calls Change
+$193K

MGNX Hedge Fund Activity: Q2 2020 in Review

137 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2020, worth a combined $1.42B — up 433% from $266M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new MGNX positions and 24 closed out — a net gain of 15 holders — while 39 added to existing stakes and 46 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $79.6M. The largest seller was Bellevue Group, cutting an estimated $19.4M.

  • 137 institutional investors held MacroGenics (MGNX) as of Q2 2020, up from 122 in Q1 2020.
  • Funds reported $1.42B of MacroGenics stock for Q2 2020, up 433% quarter-over-quarter.
  • 39 funds opened new MacroGenics positions in Q2 2020 and 24 closed out, a net change of +15 holders.
  • The largest MacroGenics buyer in Q2 2020 was RA Capital Management, an estimated $79.6M added.
  • The largest MacroGenics seller in Q2 2020 was Bellevue Group, an estimated $19.4M sold.

Based on aggregated 13F filings for Q2 2020.